LCZ696 Catalog No.:M8445-2 Smiles: CC1=NC(=CS1)/C=C(\C)/[C@@H]1C[C@@H]2O[C@@H]2CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
Pay in 4 interest-free payments of $20.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Live Spec
LCZ696 Catalog No.:M8445-2 Smiles: CC1=NC(=CS1)/C=C(\C)/[C@@H]1C[C@@H]2O[C@@H]2CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1LCZ696 is a potent ARNi inhibitor and an investigational drug to treat heart failure. Chemically, LCZ696 is a mixture of valsartan and sacubitril in a 1: 1 molar ratio. As of 2014 it is being developed by Novartis. LCZ696 is co crystallized valsartan and sacubitril, in a one to one molar ratio. According to Sci Finder database, LCZ696 has a formula as (valsartan)(sacubitril)(3Sodium)(5 2 hydrate), or (2 valsartan)(2 sacubitril) (6 Sodium)(5 hydrate),
Store: lpsgardenbuildings.co.uk · Domain: lpsgardenbuildings.co.uk

























